Cavitation dose painting for focused ultrasound-induced blood-brain barrier disruption.
Authors: Yang Y, Zhang X, Ye D, Laforest R, Williamson J, Liu Y, Chen H
Focused ultrasound combined with microbubble for blood-brain barrier disruption (FUS-BBBD) is a promising technique for noninvasive and localized brain drug delivery. This study demonstrates that passive cavitation imaging (PCI) is capable of predicting the location and concentration of nanoclusters delivered by FUS-BBBD. During FUS-BBBD treatment of mice, the acoustic emissions from FUS-activated microbubbles were passively detected by an ultrasound imaging system and processed offline using a frequency-domain PCI algorithm. After the FUS treatment, radiolabeled gold nanoclusters, <sup>64</sup>Cu-AuNCs, were intravenously injected into the mice and imaged by positron emission tomography/computed tomography (PET/CT). The centers of the stable cavitation dose (SCD) maps obtained by PCI and the corresponding centers of the <sup>64</sup>Cu-AuNCs concentration maps obtained by PET coincided within 0.3 ± 0.4 mm and 1.6 ± 1.1 mm in the transverse and axial directions of the FUS beam, respectively. The SCD maps were found to be linearly correlated with the <sup>64</sup>Cu-AuNCs concentration maps on a pixel-by-pixel level. These findings suggest that SCD maps can spatially "paint" the delivered nanocluster concentration, a technique that we named as cavitation dose painting. This PCI-based cavitation dose painting technique in combination with FUS-BBBD opens new horizons in spatially targeted and modulated brain drug delivery.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To evaluate whether passive cavitation imaging (PCI) can predict the spatial location and concentration of therapeutic agents delivered by focused ultrasound–mediated blood-brain barrier disruption (FUS-BBBD).
Animal model / Human subject
Mouse (Mus musculus), strain C57BL/6, age: 6-8 weeks, sex female
Disease model
Healthy
MRI or image guidance method
Ultrasound image guidance; B-mode ultrasound with metal grid treatment planning
Targeted brain region(s)
Brainstem
Cargo name and characteristics
Radiolabeled gold nanoclusters (64Cu-labeled Au nanoclusters), nanoparticle (PET radiotracer), intravenously administered
Route of administration
intravenous
Outcomes and Safety
Summary of Outcomes
PCI predicted the spatial distribution and concentration of 64Cu-Au nanocluster delivered by FUS-BBBD, correlating with PET measurements and supporting cavitation dose painting for targeted drug delivery.
Safety-related matter
No adverse effects were reported in the study; no safety issues or tissue damage were described. The authors note that PCI-guided FUS-BBBD could help avoid side effects in non-targeted brain areas.
Brain Region
Ultrasound Parameters
Ultrasound instrument
Ultrasound image-guided FUS system (VIFU 2000, Alpinion, Bothell, WA, USA)
FUS Frequency
1.5 MHz
FUS Pressure
0.61 Mpa
FUS Mode
pulsed
Pulse duration
6.7 ms
Duration of a single FUS session
120 s
Focal Characteristics
focal depth: 60 mm; focal length: None; aperture size: 60 mm
Treatment frequency
single
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search